Retraction
MicroRNA‑874 prohibits the proliferation and invasion of retinoblastoma cells by directly targeting metadherin
Paper Information
Record ID:
40915
Author(s):
Journal:
Publication Date:
July 16, 2018
Retraction Date:
November 23, 2022
(3.0 years years ago)
Subjects:
Institutions:
Country:
🇨🇳 ChinaArticle Type:
Publisher:
Spandidos
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Retraction Details
Retraction Reasons:
Nature of Retraction:
Retraction
Retraction Notice:
10.3892/mmr.2022.12900Additional Notes:
see also: https://pubpeer.com/publications/1C3AF0ACD23BB21DB88A90E2406F10
Citations (11)
11
Total Citations1
Post-Retraction(9.1%)
10
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
1
Within 30 days
1
Within 1 year
0
After 2+ years
30
Days since retraction (latest)
Role of non-coding RNAs and exosomal non-coding RNAs in retinoblastoma progression
Nasrin Ahangar Davoodi, Sajad Najafi, Zari Naderi Ghale-Noie et al. (12 authors)
Frontiers in Cell and Developmental Biology
Open Access
Published: Dec 2022
25 citations
25 citations
30 days after retraction
Integrated analysis of multiple bioinformatics studies to identify microRNA-target gene-transcription factor regulatory networks in retinoblastoma
Yanjun Wen, Maolin Zhu, Xuerui Zhang et al. (6 authors)
Translational Cancer Research
Open Access
Published: Jul 2022
3 citations
3 citations
145 days before retraction
miR-874: An Important Regulator in Human Diseases
Qiudan Zhang, Chenming Zhong, Qianqian Yan et al. (6 authors)
Frontiers in Cell and Developmental Biology
Open Access
Published: Apr 2022
13 citations
13 citations
231 days before retraction
MicroRNA-9 inhibits proliferation and progression in retinoblastoma cells by targeting PTEN
Manhai Gao, Zhe Cui, Dan Zhao et al. (5 authors)
Genes & Genomics
Published: Jun 2021
4 citations
4 citations
526 days before retraction
A Review of AEG-1 Oncogene Regulating MicroRNA Expression in Colon Cancer Progression
Sarubala Malayaperumal, Sushmitha Sriramulu, Ganesan Jothimani et al. (5 authors)
Endocrine Metabolic & Immune Disorders - Drug Targets
Published: Jun 2020
10 citations
10 citations
888 days before retraction
miR-874 ameliorates retinopathy in diabetic rats by NF-κB signaling pathway
Rui Li, Huimin Yuan, Tao Zhao et al. (8 authors)
Research Square (Research Square)
Open Access
Published: Jun 2020
2 citations
2 citations
904 days before retraction
miR-874 ameliorates retinopathy in diabetic rats by NF-κB signaling pathway
Rui Li, Huimin Yuan, Tao Zhao et al. (8 authors)
Research Square (Research Square)
Open Access
Published: Mar 2020
971 days before retraction
miR-874 ameliorates retinopathy in diabetic rats by NF-κB signaling pathway
Rui Li, Huimin Yuan, Tao Zhao et al. (8 authors)
Research Square (Research Square)
Open Access
Published: Jan 2020
1 citation
1 citation
1034 days before retraction
miR-874 ameliorates retinopathy in diabetic rats by NF-κB signaling pathway
Rui Li, Huimin Yuan, Tao Zhao et al. (8 authors)
Research Square (Research Square)
Open Access
Published: Sep 2019
1162 days before retraction
<p>MicroRNA-665 inhibits the oncogenicity of retinoblastoma by directly targeting high-mobility group box 1 and inactivating the Wnt/&beta;-catenin pathway</p>
Shuai Wang, Shanshan Du, Yong Lv et al. (5 authors)
Cancer Management and Research
Open Access
Published: Apr 2019
20 citations
20 citations
1332 days before retraction
Expression profiles and prognostic value of miRNAs in retinoblastoma
Lara Elis Alberici Delsin, Karina Bezerra Salomão, Julia Alejandra Pezuk et al. (4 authors)
Journal of Cancer Research and Clinical Oncology
Published: Oct 2018
35 citations
35 citations
1493 days before retraction
Quick Stats
Total Citations:
11
Years Since Retraction:
3.0 years
Open Access:
Yes
Last Checked:
Jul 24, 2025